Brief: Sellas Life Sciences Says On Jan 2, Co & Cantor Fitzgerald Agreed To Terminate Controlled Equity Offering Sales Deal, Dated April 16, 2021
03/01/2024 22:43
Jan 3 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES: ON JAN 2, CO & CANTOR FITZGERALD &
CO.
AGREED TO TERMINATE CONTROLLED EQUITY OFFERING SALES DEAL, DATED
APRIL 16, 2021
Further company coverage: SLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses